Literature DB >> 31180366

Use of a Linear Accelerator for Conducting In Vitro Radiobiology Experiments.

Jing Hao1, Anthony Magnelli2, Andrew Godley2, Jennifer S Yu3.   

Abstract

Radiation therapy remains one of the cornerstones of cancer management. For most cancers, it is the most effective, nonsurgical therapy to debulk tumors. Here, we describe a method to irradiate cancer cells with a linear accelerator. The advancement of linear accelerator technology has improved the precision and efficiency of radiation therapy. The biological effects of a wide range of radiation doses and dose rates continue to be an intense area of investigation. Use of linear accelerators can facilitate these studies using clinically relevant doses and dose rates.

Entities:  

Mesh:

Year:  2019        PMID: 31180366      PMCID: PMC7071788          DOI: 10.3791/59514

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  18 in total

1.  Effect of high dose per pulse flattening filter-free beams on cancer cell survival.

Authors:  Ines Lohse; Stephanie Lang; Jan Hrbacek; Stephan Scheidegger; Stephan Bodis; Nadia S Macedo; Jianhua Feng; Urs M Lütolf; Kathrin Zaugg
Journal:  Radiother Oncol       Date:  2011-07-04       Impact factor: 6.280

2.  Radiobiological effects of altering dose rate in filter-free photon beams.

Authors:  T Karan; V Moiseenko; B Gill; R Horwood; A Kyle; A I Minchinton
Journal:  Phys Med Biol       Date:  2013-01-31       Impact factor: 3.609

3.  Effect of varying dose-per-pulse and average dose rate in X-ray beam irradiation on cultured cell survival.

Authors:  G Lasio; M Guerrero; W Goetz; F Lima; J E Baulch
Journal:  Radiat Environ Biophys       Date:  2014-08-29       Impact factor: 1.925

4.  Radiation-induced G2/M arrest rarely occurred in glioblastoma stem-like cells.

Authors:  Junfeng Liu; Yu Liu; Tao Xie; Longjun Luo; Cheng Xu; Qinglei Gao; Lu Shen; Feng Wan; Ting Lei; Fei Ye
Journal:  Int J Radiat Biol       Date:  2018-02-27       Impact factor: 2.694

Review 5.  Radiation dose-rate: a factor of importance in radiobiology and radiotherapy.

Authors:  E J Hall
Journal:  Br J Radiol       Date:  1972-02       Impact factor: 3.039

Review 6.  The dose-rate effect in human tumour cells.

Authors:  G G Steel; J M Deacon; G M Duchesne; A Horwich; L R Kelland; J H Peacock
Journal:  Radiother Oncol       Date:  1987-08       Impact factor: 6.280

Review 7.  Hypoxia imaging in upper gastrointestinal tumors and application to radiation therapy.

Authors:  Randa Tao; Bryan Ager; Shane Lloyd; Anna Torgeson; Michelle Denney; David Gaffney; Jordan Kharofa; Steven H Lin; Albert C Koong; Yoshimi Anzai; John M Hoffman
Journal:  J Gastrointest Oncol       Date:  2018-12

8.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

Authors:  Roger Stupp; Monika E Hegi; Warren P Mason; Martin J van den Bent; Martin J B Taphoorn; Robert C Janzer; Samuel K Ludwin; Anouk Allgeier; Barbara Fisher; Karl Belanger; Peter Hau; Alba A Brandes; Johanna Gijtenbeek; Christine Marosi; Charles J Vecht; Karima Mokhtari; Pieter Wesseling; Salvador Villa; Elizabeth Eisenhauer; Thierry Gorlia; Michael Weller; Denis Lacombe; J Gregory Cairncross; René-Olivier Mirimanoff
Journal:  Lancet Oncol       Date:  2009-03-09       Impact factor: 41.316

9.  Amotosalen/UVA treatment inactivates T cells more effectively than the recommended gamma dose for prevention of transfusion-associated graft-versus-host disease.

Authors:  Grace Castro; Patricia A Merkel; Hannah E Giclas; Andrew Gibula; Gillian E Andersen; Laurence M Corash; Jin Sying Lin; Jennifer Green; Vijaya Knight; Adonis Stassinopoulos
Journal:  Transfusion       Date:  2018-04-02       Impact factor: 3.157

10.  The effects of extra high dose rate irradiation on glioma stem-like cells.

Authors:  Jing Hao; Andrew Godley; Jocelyn D Shoemake; Zheyi Han; Anthony Magnelli; Jennifer S Yu
Journal:  PLoS One       Date:  2018-08-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.